[1,2-Bis(2-hydroxyphenyl)ethylenediamine]dichloroplatinum(II), a new compound for the therapy of ovarian cancer - III. Detailed evaluation of the antitumor activity of the enantiomeric complexes on the human NIH:OVCAR-3 ovarian cancer cell line

Journal of Cancer Research and Clinical Oncology

Volumn 118, Issue 3, 1992, Pages 209-215

  Bernhardt, Günther ^a   Gust, Ronald ^a   Reile, Herta ^a   vom Orde, Hans Dieter ^a   Müller, Richard ^a   Keller, Christoph ^a   Spruß, Thilo ^a   Schönenberger, Helmut ^b   Burgemeister, Thomas ^a   Mannschreck, Albrecht ^a   Range, Klaus Jürgen ^a   Klement, Ulrich ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

^b NONE

Author keywords

Combination with buthionine sulfoximine; Evaluation on NIH:OVCAR 3 ovarian cancer cell line; Stereoisomeric 1,2 bis(2 hydroxyphenyl)ethylenediamine dichloroplatinum(II)

Indexed keywords

ANTINEOPLASTIC AGENT; BUTHIONINE SULFOXIMINE; CISPLATIN; PLATINUM 1,2 BIS(2 HYDROXYPHENYL)ETHYLENEDIAMINE DICHLORIDE; PLATINUM COMPLEX; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; DRUG RESISTANCE; ENANTIOMER; NONHUMAN; OVARY CANCER; STEREOISOMERISM;

ANTINEOPLASTIC AGENTS; BUTHIONINE SULFOXIMINE; CELL LINE; CISPLATIN; FEMALE; GLUTATHIONE; HUMAN; METHIONINE SULFOXIMINE; ORGANOPLATINUM COMPOUNDS; OVARIAN NEOPLASMS; STEREOISOMERISM; STRUCTURE-ACTIVITY RELATIONSHIP; SUPPORT, NON-U.S. GOV'T; TUMOR CELLS, CULTURED;

EID: 0026547190     PISSN: 01715216     EISSN: 14321335     Source Type: Journal    
DOI: 10.1007/BF01410136     Document Type: Article

References (23)

1. [1,2-Bis(2-hydroxyphenyl)ethylenediamine]dichloroplatinum(II), a new compound for the therapy of ovarian cancer: part II. Synthesis and testing of the eantiomeric complexes
2. Standardized kinetic microassay to quantify differential chemosensitivity based on proliferative activity
3. Potent and specific inhibition of glutathione synthesis by buthionine sulfoximine (S-n-butyl homocysteine sulfoximine)
4. Complexes of platinum(II) with chiral diamines and guanosine. Stereochemical investigation related to the mechanism of the antitumor activity of cis-bis(amine)platinum(II) type complexes
5. Enantiomeric cisplatin analogues: an investigation on their activity towards tumors in mice
6. Aqua [1(2,6-dichloro-4-hydroxyphenyl)-2-phenylethylene diamine](sulfato)platinum(II) complexes with variable substitutents in the 2-phenyl ring: 1. Synthesis and antitumor and estrogenic properties
7. Characterization of a human ovarian carcinoma cell line (NIH:OVCAR 3) with androgen and estrogen receptors
8. Inhibitory effects of anti-tumor platinum compound on DNA, RNA, and protein synthesis in mammalian cells in vitro
9. The seed stock concept and quality control for cell lines
10. Cis-Dichlorodiammineplatinum(II) persistent and selective inhibition of deoxyribonucleic acid synthesis in vivo
11. Tumor inhibiting properties of stereoisomeric [1,2-bis(3-hydroxyphenyl)ethylenediamine]dichloroplatinum(II) complexes: part II. Biological properties
12. [Dl-1,2-Bis(2-hydroxyphenyl)ethylenediamine]dichloroplatinum(II) a new compound for the therapy of ovarian cancer
13. Tumor inhibiting [1,2-bis(fluorophenyl)ethylenediamine]platinum(II) complexes: part V. Synthesis and evaluation of enantiomeric [1,2-bis(4-fluorophenyl)ethylenediamine]dichloroplatinum(II) complexes
14. Pharmacologic reversal of drug resistance in ovarian cancer
15. Sequence-dependent termination of in vitro DNA synthesis by cis- and trans-diamminedichloroplatinum(II)
16. Computerized determination of growth kinetic curves and doubling times from cells in microculture
17. Kinetic investigation of the DNA platination reaction: evidence for a transient adduct between deoxyribonucleic acid and cis-platinum(II)
18. Rezeptorgebundene Chemotherapie
19. Mechanism of cis-diamminedichloroplatinum(II)-induced cytotoxicity: role of G 2 arrest and DNA double-strand breaks
20. Characterization of the ovarian carcinomas NIH:OVCAR-3 and SK:OV-3 growing in the ovary of nude mice
21. Dichloro[1,2-bis(4-hydroxyphenyl)ethylenediamine]platinum(II) complexes: an approach to develop compounds with a specific effect on the hormone-dependent mammary carcinoma
22. The tumor inhibiting effect of isomeric dichloro(diphenylethylenediamine)platinum(II) complexes